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50 years Pt. K. case pserentation
Diagnosis
Postreumatic and atherosclerotic myocardiosclerosis, arterial 
hypertension st. I, eccentric left ventricle hypertrophy, 
analtered liftlets mitral dual protomesosystolic regurgitation st. 
I, persistent tachysystolic monomodal heart rate adaptive 
atrial flutter, HF NYHA II
ECG before treatment
atrial flutter
Active tilt-test
atrial flutter HR and hrv’ TP changes
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test changes are the 
same as in sinus rrythm’ 
patients
•HR increase
•TP decrease
DAILY AMIODARONUM (amiocordin, KRKA)
DOSE IN ATRIAL FLUTTER CARDIOVERSION
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ECG after atrial flutter
amiodaronum cardioversion
restored sinus rrythm
HR at atrial flutter 
amiodaronum cardioversion
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Heart rate tachogram at atrial flutter
amiodaronum cardioversion
Before treatment
One week treatment
2 weeks treatment
3 weeks treatment
4 weeks treatment
sinus rrythm
hrv’ TP at atrial flutter
amiodaronum cardioversion
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RR-scaterogram at atrial flutter
amiodaronum cardioversion
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RR-distribution at atrial flutter
amiodaronum cardioversion
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hrv’ spectrogram at atrial flutter 
amiodaronum cardioversion
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Attention! Different pictures have different scale
hrv’ TP dinamic is the critery of artial flutter 
sensivity to the drug therapy
• hrv’ TP is the measure of atrial flutter chaotic 
degree 
• hrv’ TP fall during therapy is the evidence of  
atrial flutter chaotic sensivity to the drug
• Bigger sensivity means bigger effectiveness
Let use effective reduce atrial flutter hrv’ TP drugs!
Amiodaronum satellite conclusion
• Amiodaronum regularizes atrial 
flutter heart rrythm
• Amiodaronum leads atrial flutter 
heart rate out to the more 
probably in hrv’ frequency  
• Criterion of prospective
pharmacotherapeutic cardioversion 
is an effective hrv’ TP fall
